Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests
KA Bates, G Verdile, Q-X Li, D Ames, P Hudson, CL Masters, RN Martins
Molecular Psychiatry | NATURE PUBLISHING GROUP | Published : 2009
Awarded by National Institutes of Health
This work was supported through research grant funding from the National Health and Medical Research Council of Australia, the Dementia Collaborative Research Centre, the Australian Biomarkers, Imaging and Lifestyle Flagship study of Ageing and the National Institutes of Health (project ID 52070400). KAB, GV and RNM acknowledge the Centre of Excellence for Alzheimer's Disease Research and Care and The McCusker Foundation for Alzheimer's disease Research for additional support. We also acknowledge editorial assistance from Miss Tamar Berger.